Center-Authored Papers

Filters: Author is Dienstmann, Rodrigo  [Clear All Filters]
2014
Dienstmann R, Tabernero J.  2014.  TGR analysis in phase I clinical trials--letter.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(9):2495-6.
Guinney J, Dienstmann R, Ferté C, Friend S, McCormick F.  2014.  Social interactomes for enabling research communities.. Cancer discovery. 4(11):1265-8. Abstract
2015
Dienstmann R, Jang IS, Bot B, Friend S, Guinney J.  2015.  Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.. Cancer discovery. 5(2):118-23. Abstract
Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R.  2015.  Intrinsic cancer subtypes--next steps into personalized medicine.. Cellular oncology (Dordrecht). 38(1):3-16. Abstract
Dienstmann R, Salazar R, Tabernero J.  2015.  Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(16):1787-1796. Abstract
Dienstmann R, Salazar R, Tabernero J.  2015.  Genomic testing in colorectal cancer: how much is enough? Oncology (Williston Park, N.Y.). 29(3):186-8.
Dienstmann R, Rodon J, Tabernero J.  2015.  Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.. Molecular oncology. 9(5):940-950. Abstract
2017
Roumeliotis TI, Williams SP, Gonçalves E, Alsinet C, Del Castillo Velasco-Herrera M, Aben N, Ghavidel FZ, Michaut M, Schubert M, Price S et al..  2017.  Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells.. Cell reports. 20(9):2201-2214. Abstract
Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J.  2017.  Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.. Nature reviews. Cancer. Abstract